The body, upgraded.
A cool-eyed survey of the movement that says human nature is not the finish line. From cochlear implants to mind uploads, what is now medicine, what is enhancement, and what is still pure manifesto?
What "transhumanism" means in 2026
Transhumanism is the philosophical claim that we should use technology to extend human capacities — physical, cognitive, emotional — beyond evolved norms. The term goes back to Julian Huxley (1957). The contemporary movement crystallized with Max More (1990), Nick Bostrom & David Pearce (1998 WTA / Humanity+), and the Extropians.
It is not transhumanism if it merely cures disease. It becomes transhumanism when the same techniques are pressed past baseline — to lifespans of 150, IQ +30, sensory ranges that birds and bats have but we never did.
- Perpetual progress — open-ended improvement
- Self-transformation — biological & psychological enhancement
- Practical optimism — "dynamic optimism", action-oriented
Extropianism · Posthumanism · Longevism · Singularitarianism · Effective Accelerationism (e/acc)
Four directions of upgrade
What is shipping
| Tech | Stage | Notable | Year |
|---|---|---|---|
| Cochlear implants | Approved · 1m+ users | FDA 1984 | 1984 |
| Deep brain stimulation | Approved · Parkinson's, OCD | ~200k implants | 1997 |
| Retinal prosthesis | Limited · Argus-II discontinued | Pixium IRIS-II | 2013–25 |
| Neuralink N1 | FDA-cleared trials, ~3 patients | Telepathy demo, 2024 | 2024– |
| Synchron Stentrode | FDA breakthrough · vascular BCI | thought-cursor for ALS | 2022– |
| CRISPR (Casgevy) | Approved · sickle-cell, β-thalassemia | Vertex / CRISPR Tx | 2023 |
| GLP-1 agonists | Mass adoption · weight, addiction trials | semaglutide, tirzepatide | 2017– |
| Senolytics | Phase II trials | UNITY, Mayo | 2018– |
| Mind uploading | Concept only | connectomics datasets | — |
How a brain-computer interface listens in
BCIs span a spectrum from non-invasive (EEG, ~10⁰ neurons resolved) to fully invasive (Utah arrays, Neuralink threads, ~10³ neurons). Bandwidth scales with electrode count, but so do tissue-rejection problems.
How long, really?
Aubrey de Grey's SENS framework (2002) categorizes seven types of cellular damage. It is no longer a fringe view: NIH's Interventions Testing Program, Calico, Altos Labs, and Loyal (dog longevity) have absorbed billions in capital. The hard claim — "longevity escape velocity by 2030" — remains a minority position even among researchers who agree aging is intervenable.
What might actually move the needle
- Senolytics (clearing senescent cells)
- Partial reprogramming (Yamanaka factors, in vivo)
- Rapamycin / mTOR axis
- Mitochondrial uncouplers (DNP analogues, careful)
- Plasma factor exchange (TPE)
forecast Healthspan extension of 5–10 years by 2050 is plausible. Lifespan to 150 by 2050 is not.
Smarter, or just augmented?
Pharmacological cognitive enhancement (modafinil, methylphenidate, amphetamines) has modest, dose-dependent effects on attention. Benefits in healthy subjects often vanish in well-controlled trials. The most consequential cognitive upgrade of the 2020s is not a pill — it is an LLM in your pocket.
Who shaped the conversation
| Nick Bostrom | FHI Oxford. Superintelligence (2014); the simulation argument; existential risk. |
| David Pearce | Hedonistic Imperative; abolitionism — engineering away suffering. |
| Ray Kurzweil | The Singularity Is Near (2005); accelerating returns; nano-bots in capillaries. |
| Aubrey de Grey | SENS, longevity escape velocity; controversial within mainstream gerontology. |
| Anders Sandberg | Whole-brain emulation roadmap (2008, FHI). |
| Donna Haraway | "A Cyborg Manifesto" (1985); the founding feminist text on hybridity. |
| Francis Fukuyama | Critic. Our Posthuman Future (2002), called transhumanism "the world's most dangerous idea". |
| Leon Kass | Bioconservative; Bush bioethics council; defends "the wisdom of repugnance". |
The five hard arguments
- Inequality. If enhancement requires capital, you fork the species along wealth lines. (Sandel; Persson & Savulescu.)
- Authenticity. Is a CRISPR-edited child still "your" child? Is a memory you didn't form "your" memory?
- Coercion. Once enhancement is normal, opting out costs you the job, the SAT score, the marriage market.
- Reversibility. Germline edits are inheritable. Mistakes propagate.
- Identity. If you replace neurons gradually with chips, when (if ever) does "you" stop being you? (Parfit's bundle theory.)
Enhancement spectrum & regulatory zones
What stays speculative
- Whole-brain emulation. Sandberg & Bostrom (2008) put the compute requirement around 10¹⁴–10¹⁸ FLOPS, plausibly in reach by 2030s. Scanning resolution is the harder bottleneck — destructive serial-section EM still required. scenario
- Morphological freedom. Designed bodies, optional sensory modes, optional substrates. Manfred Macx, not 2030. fiction-adjacent
- Pearce's pleasure-engineering. A "hedonic floor" lifted by gene therapy — phenomenologically plausible, politically nowhere. fiction-adjacent
- Suspended animation / cryonics. Alcor and Cryonics Institute have ~500 patients. No reanimation pathway demonstrated. scenario
What if we nuke aging?
10-minute primer on senescence, partial reprogramming, and the most plausible levers. Designed for skeptics.
youtube.com/@kurzgesagt →Conversations with Bostrom, Hassabis, and Aubrey de Grey
Multi-hour interviews — slow, patient, contradicts itself across episodes. Useful precisely for that.
youtube.com/@lexfridman →What to watch · 2026–2030
- Neuralink & Synchron multi-patient endpoints (typing speed, longevity)
- First in-vivo partial-reprogramming clinical trial (Altos, Calico)
- FDA pathway for "aging" as an indication (TAME trial readout)
- Germline editing moratorium status — China, UK Parliament debates
- GLP-1 long-term cognition data at scale
// END FILE 06.02 // The body is a draft.